Acro Biomedical (ACBM) Total Debt Growth (3y) (2019 - 2022)
Acro Biomedical (ACBM) Total Debt Growth (3y) (2019 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.93 Mn | 477.93 Mn | - | - |
| 2 | GP-Act III Acquisition | 312.80 Mn | 312.80 Mn | - | - |
| 3 | Berto Acquisition | 311.56 Mn | 311.56 Mn | - | - |
| 4 | Churchill Capital Corp IX | 310.79 Mn | 310.79 Mn | - | - |
| 5 | Centurion Acquisition | 310.21 Mn | 310.21 Mn | - | - |
| 6 | WEN Acquisition | 309.15 Mn | 309.15 Mn | - | - |
| 7 | Agriculture & Natural Solutions Acquisition | 303.81 Mn | 303.81 Mn | - | - |
| 8 | Bold Eagle Acquisition | 274.64 Mn | 274.64 Mn | - | - |
| 9 | Live Oak Acquisition Corp. V | 265.88 Mn | 265.88 Mn | - | - |
| 10 | Acro Biomedical | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 81.70% |
| Sep 30, 2022 | 8.36% |
| Jun 30, 2022 | -40.99% |
| Mar 31, 2022 | 4.54% |
| Dec 31, 2021 | 133.32% |
| Sep 30, 2021 | -48.17% |
| Jun 30, 2021 | -51.59% |
| Mar 31, 2021 | 39.30% |
| Dec 30, 2020 | 80.42% |
| Sep 30, 2020 | 72.88% |
| Jun 30, 2020 | 67.58% |
| Mar 31, 2020 | 92.38% |
| Dec 31, 2019 | 38.00% |
| Sep 30, 2019 | 83.48% |